Free Trial

Short Interest in Shandong Weigao Group Medical Polymer Company Limited (OTCMKTS:SHWGF) Drops By 98.7%

Shandong Weigao Group Medical Polymer logo with Medical background

Shandong Weigao Group Medical Polymer Company Limited (OTCMKTS:SHWGF - Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 33,800 shares, a drop of 98.7% from the September 30th total of 2,541,300 shares. Based on an average trading volume of 4,400 shares, the days-to-cover ratio is currently 7.7 days.

Shandong Weigao Group Medical Polymer Price Performance

OTCMKTS SHWGF remained flat at $0.96 on Friday. The business has a 50 day moving average of $0.96 and a two-hundred day moving average of $0.96. The company has a current ratio of 3.28, a quick ratio of 2.89 and a debt-to-equity ratio of 0.14. Shandong Weigao Group Medical Polymer has a 12-month low of $0.96 and a 12-month high of $0.97.

Shandong Weigao Group Medical Polymer Company Profile

(Get Free Report)

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Trump won. Buy this coin now. (From Weiss Ratings) (Ad)

Should you invest $1,000 in Shandong Weigao Group Medical Polymer right now?

Before you consider Shandong Weigao Group Medical Polymer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shandong Weigao Group Medical Polymer wasn't on the list.

While Shandong Weigao Group Medical Polymer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines